| Filed On | Filing |
|---|---|
| 16 Jun 2026 | 25-NSE |
| 12 Feb 2021 | ASSERTIO THERAPEUTICS, INC |
| 18 Jun 2020 | 15-12B |
| 22 May 2020 | 8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more |
| 19 May 2020 | 25-NSE |
| 18 May 2020 | DEFA14A |
| 11 May 2020 | 425 |
| 11 May 2020 |
Form 4: Dawes Karen A, Director
Sold 15,834 shares ($12.5K) |
| 11 May 2020 | 10-Q |
| 11 May 2020 | 8-K: Results of Operations and Financial Condition; Other Events |
| 24 Apr 2020 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 21 Apr 2020 | 8-K |
| 21 Apr 2020 | 8-K: Other Events |
| 20 Apr 2020 | DEF 14A |
| 08 Apr 2020 | SC TO-I/A |
| 08 Apr 2020 | 8-K: Regulation FD Disclosure |
| 03 Apr 2020 |
Form 4/A: Bukofzer Stan, SVP, Chf Scitfc & Tech Officer
Received 25,370 shares by exercise or conversion · Gave up 7,433 shares to cover exercise price or tax ($4.81K) |
| 03 Apr 2020 |
Form 4: Bukofzer Stan, SVP, Chf Scitfc & Tech Officer
Received 25,370 shares by exercise or conversion · Gave up 7,433 shares to cover exercise price or tax |
| 31 Mar 2020 |
Form 4: Galeota James Jr, Director
Received 12,492 shares by exercise or conversion |
| 26 Mar 2020 | SC 13D |
Loading...
